Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 23708659
Wu CF, et al. (2014) RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B. Oncogene 33, 2385-94 23708659
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S293-p - CDC25A (human)
Modsite: GSTKrRKsMsGASPk SwissProt Entrez-Gene
Orthologous residues
CDC25A (human): S293‑p, CDC25A iso2 (human): S253‑p, CDC25A (mouse): S284‑p, CDC25A (rat): S296‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  prostate cancer
Relevant cell lines - cell types - tissues:  293 (epithelial), PC3 (prostate cell)
Cellular systems studied:  cell lines
Species studied:  human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE p90RSK (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE p90RSK (human) phospho-antibody, pharmacological inhibitor of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
BI-D1870 decrease
SL0101 decrease

S295-p - CDC25A (human)
Modsite: TKrRKsMsGASPkES SwissProt Entrez-Gene
Orthologous residues
CDC25A (human): S295‑p, CDC25A iso2 (human): S255‑p, CDC25A (mouse): P286‑p, CDC25A (rat): S297‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  prostate cancer
Relevant cell lines - cell types - tissues:  293 (epithelial), PC3 (prostate cell)
Cellular systems studied:  cell lines
Species studied:  human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE p90RSK (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE p90RSK (human) phospho-antibody, pharmacological inhibitor of upstream enzyme

S353-p - CDC25B (human)
Modsite: VQNkRRRsVtPPEEQ SwissProt Entrez-Gene
Orthologous residues
CDC25B (human): S353‑p, CDC25B iso2 (human): S339‑p, CDC25B iso3 (human): S312‑p, CDC25B (mouse): S351‑p, CDC25B (rat): S349‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  prostate cancer
Relevant cell lines - cell types - tissues:  293 (epithelial), PC3 (prostate cell)
Cellular systems studied:  cell lines
Species studied:  human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE p90RSK (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE p90RSK (human) phospho-antibody, pharmacological inhibitor of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
BI-D1870 decrease
SL0101 decrease

T355-p - CDC25B (human)
Modsite: NkRRRsVtPPEEQQE SwissProt Entrez-Gene
Orthologous residues
CDC25B (human): T355‑p, CDC25B iso2 (human): T341‑p, CDC25B iso3 (human): T314‑p, CDC25B (mouse): T353‑p, CDC25B (rat): T351‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  prostate cancer
Relevant cell lines - cell types - tissues:  293 (epithelial), PC3 (prostate cell)
Cellular systems studied:  cell lines
Species studied:  human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE p90RSK (human)
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE p90RSK (human) phospho-antibody, pharmacological inhibitor of upstream enzyme

S247-p - CDC25C (human)
Modsite: kVKKkYFsGQGkLRK SwissProt Entrez-Gene
Orthologous residues
CDC25C (human): S247‑p, CDC25C iso3 (human): S204‑p, CDC25C (mouse): , CDC25C (frog): T318‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  prostate cancer
Relevant cell lines - cell types - tissues:  293 (epithelial), PC3 (prostate cell)
Cellular systems studied:  cell lines
Species studied:  human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE p90RSK (human)

T359-p - p90RSK (human)
Modsite: DTEFTSRtPKDsPGI SwissProt Entrez-Gene
Orthologous residues
p90RSK (human): T359‑p, p90RSK iso2 (human): T368‑p, p90RSK (mouse): T348‑p, p90RSK iso3 (mouse): , p90RSK (rat): T359‑p, p90RSK (chicken): T377‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, phospho-antibody, western blotting
Disease tissue studied:  prostate cancer
Relevant cell lines - cell types - tissues:  293 (epithelial), PC3 (prostate cell)
Cellular systems studied:  cell lines
Species studied:  human
Downstream Regulation
Effect of modification (function):  enzymatic activity, induced

S363-p - p90RSK (human)
Modsite: TSRtPKDsPGIPPsA SwissProt Entrez-Gene
Orthologous residues
p90RSK (human): S363‑p, p90RSK iso2 (human): S372‑p, p90RSK (mouse): S352‑p, p90RSK iso3 (mouse): , p90RSK (rat): S363‑p, p90RSK (chicken): S381‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, phospho-antibody, western blotting
Disease tissue studied:  prostate cancer
Relevant cell lines - cell types - tissues:  293 (epithelial), PC3 (prostate cell)
Cellular systems studied:  cell lines
Species studied:  human
Downstream Regulation
Effect of modification (function):  enzymatic activity, induced

S227-p - RSK2 (human)
Modsite: DHEKKAysFCGtVEy SwissProt Entrez-Gene
Orthologous residues
RSK2 (human): S227‑p, RSK2 (mouse): S227‑p, RSK2 (rat): S227‑p, RSK2 (cow): S227‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, phospho-antibody, western blotting
Disease tissue studied:  prostate cancer
Relevant cell lines - cell types - tissues:  293 (epithelial), PC3 (prostate cell)
Cellular systems studied:  cell lines
Species studied:  human
Downstream Regulation
Effect of modification (function):  enzymatic activity, induced